SynthesisFrontiers in immunology2023

PD-1/PD-L1 immune checkpoint inhibitors in metastatic triple-negative breast cancer: a systematic review and meta-analysis.

Yinan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.